IDEXX Laboratories Valuation
| 0J8P Stock | 439.71 7.14 1.60% |
At this time, the firm appears to be overvalued. IDEXX Laboratories retains a regular Real Value of USD347.37 per share. The prevalent price of the firm is USD439.71. Our model calculates the value of IDEXX Laboratories from inspecting the firm fundamentals such as Return On Asset of 0.23, operating margin of 0.37 %, and Return On Equity of 0.59 as well as reviewing its technical indicators and probability of bankruptcy.
Enterprise Value 37.3 B | Price Sales 10.0394 | Trailing PE 0.5247 |
Overvalued
Today
Please note that IDEXX Laboratories' price fluctuation is very steady at this time. Calculation of the real value of IDEXX Laboratories is based on 3 months time horizon. Increasing IDEXX Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the IDEXX stock is determined by what a typical buyer is willing to pay for full or partial control of IDEXX Laboratories. Since IDEXX Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IDEXX Stock. However, IDEXX Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 439.71 | Real 347.37 | Hype 439.95 | Naive 448.88 |
The intrinsic value of IDEXX Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IDEXX Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of IDEXX Laboratories helps investors to forecast how IDEXX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IDEXX Laboratories more accurately as focusing exclusively on IDEXX Laboratories' fundamentals will not take into account other important factors: IDEXX Laboratories Cash |
|
IDEXX Laboratories Total Value Analysis
IDEXX Laboratories is presently projected to have takeover price of 37.25 B with market capitalization of 3.86 T, debt of 1.07 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the IDEXX Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
37.25 B | 3.86 T | 1.07 B |
IDEXX Laboratories Investor Information
About 94.0% of the company shares are owned by institutions such as pension funds. The company recorded earning per share (EPS) of 8.52. IDEXX Laboratories had not issued any dividends in recent years. Based on the key indicators related to IDEXX Laboratories' liquidity, profitability, solvency, and operating efficiency, IDEXX Laboratories is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 951.8 M | 906.5 M |
|
| |||||
| Operating Income | 1.2 B | 1.1 B |
|
|
IDEXX Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IDEXX Laboratories has an asset utilization ratio of 112.3 percent. This implies that the Company is making USD1.12 for each dollar of assets. An increasing asset utilization means that IDEXX Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.IDEXX Laboratories Ownership Allocation
IDEXX Laboratories has a total of 86.23 Million outstanding shares. The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.IDEXX Laboratories Profitability Analysis
The company reported the revenue of 3.66 B. Net Income was 845.04 M with profit before overhead, payroll, taxes, and interest of 2 B.About IDEXX Laboratories Valuation
The stock valuation mechanism determines IDEXX Laboratories' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of IDEXX Laboratories based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of IDEXX Laboratories. We calculate exposure to IDEXX Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IDEXX Laboratories's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.2 B | 2.3 B |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.